Curacyte’s hemoximer (Pyridoxalated Hemoglobin Polyoxyethylene, PHP) has been developed as a scavenger of nitric oxide, the main causative agent responsible for vasodilation and hypotension in shock. Hemoximer has
Under terms of this agreement, Inverness Medical Innovations will have semi-exclusive global rights to commercialize products using the BioCurex-discovered RECAF blood tests for cancer detection. BioCurex will be
The company will continue to utilize PDI’s Select Access team for an additional two seasons to reach primary care physicians and will be exclusive to pediatric targets. This
Since the recent introduction of a negative pressure device by Innovative Therapies (ITI), Kinetic Concepts (KCI) has discovered that the device unlawfully incorporates inventions covered by the three
Q-Med will eventually be responsible for the marketing, advertising, promotion, sale and distribution of Palomar’s professional products for aesthetic treatments outside North America. In addition, Palomar and Q-Med
Mr. Tasse succeeds David Shaw, who has served as chairman and interim CEO since the creation of Ikaria in March 2007 and will now serve as executive chairman
This Food and Drug Branch (FDB) approval enables Hiemstra to be a valuable manufacturing resource for customers through first-in-man, ongoing clinical trials, and low-to-mid volume production needs during
The new contract will facilitate Regency’s expanded use of our Roma3 pulsed electromagnetic field (PEMF) device for the treatment of chronic wounds. Under the terms of the agreement,
In addition to Channel Medical Partners, other investors include Lincoln Funds International and existing investors Canadian Medical Discoveries Fund and Morningside Technology Ventures. In conjunction with this financing,
Genedata said that it will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide. Genedata Screener is expected to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.